Cornell Pochily Investment Advisors’s AstraZeneca AZN Stock Holding History

Cornell Pochily Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,928	Closed	-$269K	–	178
2025 Q2	$269K	Buy	+1,928	New	+$270K	0.09%	149
2025 Q1	–	Sell	-1,928	Closed	-$253K	–	166
2024 Q4	$253K	Hold	1,928	–	–	0.09%	147
2024 Q3	$300K	Hold	1,928	–	–	0.1%	142
2024 Q2	$301K	Hold	1,928	–	–	0.11%	135
2024 Q1	$261K	Hold	1,928	–	–	0.1%	148
2023 Q4	$260K	Sell	1,928 -1,000	-34%	-$130K	0.11%	151
2023 Q3	$397K	Hold	2,928	–	–	0.17%	124
2023 Q2	$419K	Sell	2,928 -1,464	-33%	-$215K	0.17%	124
2023 Q1	$610K	Hold	4,392	–	–	0.26%	102
2022 Q4	$595K	Hold	4,392	–	–	0.27%	99
2022 Q3	$482K	Hold	4,392	–	–	0.21%	107
2022 Q2	$580K	Hold	4,392	–	–	0.26%	104
2022 Q1	$583K	Buy	4,392 +1,135	+35%	+$136K	0.23%	106
2021 Q4	$379K	Hold	3,257	–	–	0.15%	128
2021 Q3	$391K	Hold	3,257	–	–	0.17%	119
2021 Q2	$390K	Buy	+3,257	New	+$357K	0.17%	122
2021 Q1	–	Sell	-2,241	Closed	-$224K	–	148
2020 Q4	$224K	Hold	2,241	–	–	0.11%	136
2020 Q3	$246K	Buy	+2,241	New	+$249K	0.14%	126

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cornell Pochily Investment Advisors's AZN Position: Q3 2025 in Review

Cornell Pochily Investment Advisors sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 1,928 shares — an estimated $269K sold.

Cornell Pochily Investment Advisors first reported a position in AZN in Q3 2020 and held it in 18 quarters. The position peaked at $610K in Q1 2023. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

Cornell Pochily Investment Advisors reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
Cornell Pochily Investment Advisors sold 1,928 AstraZeneca shares in Q3 2025, an estimated $269K.
Cornell Pochily Investment Advisors first reported a position in AstraZeneca in Q3 2020 and held it in 18 quarters.
Cornell Pochily Investment Advisors's AstraZeneca position peaked at $610K in Q1 2023.
1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Cornell Pochily Investment Advisors's 13F filing for Q3 2025, filed 27 Oct 2025.